Philippe Friedlich, MD, MSEpi, MBA News

A clinical trial at CHLA is studying virus-specific T-cell therapy as a potential treatment for newborns with congenital cytomegalovirus.

A CHLA study used natural language processing to examine the prevalence and risk factors for blood clots in NICU babies with central lines.

A CHLA study finds that preterm birth accounts for nearly a quarter of mortality in babies with congenital diaphragmatic hernia.

A biomedical engineer, Dr. Borzage collaborates with multiple CHLA researchers to study how certain conditions affect the brain’s blood vessels and metabolism.

He received lifesaving care as a baby. Now 16, Caden is raising funds for the hospital as a Junior Ambassador—and hopes to inspire others.

Ann was born perfectly healthy, but about 90 minutes later nurses discovered her unresponsive. She was transferred to Children’s Hospital Los Angeles where she received lifesaving care.

Researchers are using novel MRI techniques to uncover what happens in a baby’s brain during anesthesia.

New study identifies factors that may help predict which neonatal ECMO patients will have to return to the hospital.

A streamlined process speeds emergency transport response times, bringing lifesaving care to newborns.

Program helps prevent unplanned extubations in the NICCU.